Skip Ribbon Commands
Skip to main content
SharePoint

NATIONAL INJECTABLE OPIOID AGONIST TREATMENT GUIDELINE

CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.


A synopsis of the Guideline was published in the Canadian Medical Association Journal

A podcast was also produced by CMAJ, which can be found at the link above.

You can also access the Guideline Development Methodology (as supplied by the authors) here 

 

SUPPLEMENTAL MATERIALS


Supervised Consumption Sites vs iOAT English | French

Sample Program Expectations English | French

Sample Patient Bill of Rights English | French

Sample Client Safety Care Plan English | French

Sample Treatment Plan English | French

Sample Floor Plan English | French

Lessons Learned English | French

FAQ for Patients and Families English | French

Case Studies English | French

Sample Diacetylmorphine Titration Pre-Printed Order English | French

Sample Hydromorphone Titration Pre-Printed Order English | French

Sample Hydromorphone Titration Hospital Pre-Printed Order Package English | French

Sample Hydromorphone Maintenance Pre-Printed Order English | French

Journal Article: Perspectives of people with opioid use disorder on improving addiction treatments and services (Lachapelle, et al, 2020) English